Sugi Predict

Sugi Predict / Compounds / SCHEMBL25935196

SCHEMBL25935196

SCHEMBL25935196

CC(C)(C)OC(=O)NN1CC2(CCNCC2)C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ LIPE Q05469 1/20 0.32
▸ USP2 O75604 2/20 0.32
▸ CYP2D6 P10635 2/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ KMT2A Q03164 2/20 0.31
▸ MMP3 P08254 2/20 0.31
▸ MMP10 P09238 2/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ CYP2C9 P11712 1/20 0.30
▸ GABRD O14764 1/20 0.30
▸ GABRA1 P14867 1/20 0.30
▸ GABRB1 P18505 1/20 0.30
▸ GABRA5 P31644 1/20 0.30
▸ GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4506479 0.84 TSHR (0.39) CYP1A2CYP3A4CYP2C19LIPE
SCHEMBL853648 0.78 GNAI3 (0.41) LIPEUSP2KMT2AMEN1GAA
SCHEMBL20669168 0.76 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19USP2CYP2D6
SCHEMBL20669355 0.76 CYP1A2 (0.43) CYP1A2CYP3A4CYP2C19USP2CYP2D6
SCHEMBL20669413 0.76 MEN1 (0.49) CYP1A2CYP3A4CYP2C19USP2CYP2D6
SCHEMBL484569 0.76 ACACB (0.43) CYP1A2USP2MAPK1
Hydrochloric Acid SCHEMBL994315 0.74 ACACB (0.42) CYP1A2USP2MAPK1
SCHEMBL30136046 0.74 EPHX1 (0.37) KMT2A
SCHEMBL7151133 0.73 GNAI3 (0.38) LIPEGAA
SCHEMBL13398353 0.72 CTSK (0.34) LIPEUSP2KMT2AMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939334-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers UPPTHERA, INC. (KR) 2024-03-26 — — US disclosed
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 — — US disclosed
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 — — US disclosed
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-08-03 — — US disclosed
EP-4157850-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND Uppthera, Inc. (KR) 2023-04-05 — — EP disclosed
WO-2023018236-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-02-16 — — WO disclosed
WO-2023017446-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND UPPTHERA, INC. (KR) 2023-02-16 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11939334-B2 Substituted pyrimido[4,5-b][1,4]diazepines as PLK1 degradation inducers PLK1, BUB1B, BUB1 CYP1A2 3880/4885CYP3A4 3898/4885CYP2C19 4332/4885
US-20230242541-A1 NOVEL PLK1 DEGRADATION INDUCING COMPOUND PLK1, BUB1B, BUB1 CYP1A2 4728/4885CYP3A4 4760/4885CYP2C19 4861/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.